Company News

Share this article:
Heritage Pharmaceuticals and Ipca Laboratories have entered in to a strategic alliance for the development, supply and marketing of generic pharmaceutical products for the US prescription drug market. Under the agreement, Ipca shall develop and register selected products for US ANDA submission and Heritage retains sales and marketing rights to such products. The parties shall share net profits from the sales proceeds post-launch. Heritage Pharmaceuticals Inc. is an emerging generic pharmaceutical company engaged in the acquisition, licensing, development, marketing, sale and distribution of generic pharmaceutical products for the global prescription drug markets. Heritage launched its US label in 2006. Ipca Laboratories, based in Mumbai, India, is engaged in the manufacturing and marketing of a range of pharmaceuticals with a focus on international business.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Apple selfies spur diabetes donations

Jazz apples has launched a Crunch to Contribute campaign to raise money for one of two diabetes associations.

Baxter seeks Cambridge, Mass. HQ

Illinois may be tempted to offer tax incentives for the firm to stay put.

FDA wants Alexion to clean up

FDA inspectors have cited the manufacturer of the rare-disease drug Soliris (eculizumab) for poor manufacturing practices.